Drug Enforcement D-015-2014

Marketed Without An Approved NDA/ANDA: FDA analysis found the product to contain sulfoaildenafil, an analogue of sildenafil which is an ingredient in an FDA-approved drug for the treatment of male erectile dysfunction, making this an unapproved new drug.

Status

Terminated

Classification

Class I

Report Date

November 27, 2013

Termination Date

November 27, 2013

Product Information

Product description
Affirm XL Nutritional Supplement, 1 and 10 count blister packs and single pill packs, Manufactured by Dongseo Biopharm Corp., Yongin City, Kyonggi do, Korea, distributed by: Affirm XL, LLC, Ladera Ranch, CA
Product quantity
400 pills
Reason for recall
Marketed Without An Approved NDA/ANDA: FDA analysis found the product to contain sulfoaildenafil, an analogue of sildenafil which is an ingredient in an FDA-approved drug for the treatment of male erectile dysfunction, making this an unapproved new drug.
Recall initiation reason
Initial firm notification
Press Release
Distribution pattern
Nationwide in the US and Canada

Location & Firm

Recalling firm
Affirm XL, Inc.
Address
27702 Crown Valley Pkway D-4, #195

United States
Voluntary / Mandated
Voluntary: Firm initiated
Status date

Codes & Dates

Recall number
D-015-2014
Event ID
64878
Recall initiation date
April 10, 2013
Center classification date
November 20, 2013
Code info
Lot# 1190001, exp 12/30/2013
More code info